Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics

被引：0
|
作者：
Nael Al Koudsi
Jill C. Mwenifumbo
Edward M. Sellers
Neal L. Benowitz
Gary E. Swan
Rachel F. Tyndale
机构：
[1] University of Toronto,Centre for Addiction & Mental Health, and Department of Pharmacology
[2] University of California,Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, and Departments of Medicine, Psychiatry and Biopharmaceutical Sciences
[3] SRI International,Center for Health Sciences
[4] University of Toronto,undefined
来源：
European Journal of Clinical Pharmacology | 2006年 / 62卷
关键词：
CYP2A6; Nicotine metabolism; Polymorphism; Pharmacogenetics; Smoking;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：481 / 484
页数：3
相关论文
共 50 条
  • [1] Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics
    Al Koudsi, Nael
    Mwenifumbo, Jill C.
    Sellers, Edward M.
    Benowitz, Neal L.
    Swan, Gary E.
    Tyndale, Rachel F.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (06) : 481 - 484
  • [2] A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo
    Al Koudsi, Nael
    Ahluwalia, Jasjit S.
    Lin, Shih-Ku
    Sellers, Edward M.
    Tyndale, Rachel F.
    PHARMACOGENOMICS JOURNAL, 2009, 9 (04) : 274 - 282
  • [3] A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo
    Nael Al Koudsi
    Jasjit S Ahluwalia
    Shih-Ku Lin
    Edward M Sellers
    Rachel F Tyndale
    The Pharmacogenomics Journal, 2009, 9 : 274 - 282
  • [4] Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method
    Mwenifumbo, JC
    Myers, MG
    Wall, TL
    Lin, SK
    Sellers, EM
    Tyndale, RF
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (03) : 189 - 192
  • [5] Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo
    Piliguian, Mark
    Zhu, Andy Z. X.
    Zhou, Qian
    Benowitz, Neal L.
    Ahluwalia, Jasjit S.
    Cox, Lisa Sanderson
    Tyndale, Rachel F.
    PHARMACOGENETICS AND GENOMICS, 2014, 24 (02) : 118 - 128
  • [6] Functional Characterization of Cytochrome P450 2A6 Allelic Variants CYP2A6*15, CYP2A6*16, CYP2A6*21, and CYP2A6*22
    Tiong, Kai Hung
    Yiap, Beow Chin
    Tan, Eng Lai
    Ismail, Rusli
    Ong, Chin Eng
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (05) : 745 - 751
  • [7] A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent
    Ho, Man Ki
    Mwenifumbo, Jill C.
    Zhao, Bin
    Gillam, Elizabeth M. J.
    Tyndale, Rachel F.
    PHARMACOGENETICS AND GENOMICS, 2008, 18 (01) : 67 - 75
  • [8] Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of black African descent
    Mwenifumbo, Jill C.
    Al Koudsi, Nael
    Ho, Man Ki
    Zhou, Qian
    Hoffmann, Ewa B.
    Sellers, Edward M.
    Tyndale, Rachel F.
    HUMAN MUTATION, 2008, 29 (05) : 679 - 688
  • [9] Genetic variability in CYP2A6 and the pharmacokinetics of nicotine
    Mwenifiumbo, Jill C.
    Tyndale, Rachel F.
    PHARMACOGENOMICS, 2007, 8 (10) : 1385 - 1402
  • [10] Association Between Nicotine Metabolism and CYP2A6*1 and CYP2A6*4 Genotypes in an Iranian Population
    Heravi, Reza Entezari
    Ramezani, Mohammad
    Behravan, Javad
    DNA AND CELL BIOLOGY, 2010, 29 (07) : 369 - 373
12345